Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.38 |
| ▸ | MPL | P40238 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | POLB | P06746 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | RECQL | P46063 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | MEP1B | Q16820 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CASP6 | P55212 | 1/20 | 0.36 |
| ▸ | ELAVL1 | Q15717 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.36 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.36 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.36 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30723203 | 1.00 | GAA (0.39) | GAAHSD17B10AMY1AMPLALDH1A1 | |
| SCHEMBL5718625 | 0.96 | GAA (0.39) | GAAHSD17B10AMY1AMPLALDH1A1 | |
| SCHEMBL29975298 | 0.96 | GAA (0.39) | GAAHSD17B10AMY1AMPLALDH1A1 | |
| SCHEMBL8082255 | 0.95 | GAA (0.38) | GAAHSD17B10AMY1AMPLALDH1A1 | |
| SCHEMBL8086471 | 0.95 | GAA (0.38) | GAAHSD17B10AMY1AMPLALDH1A1 | |
| SCHEMBL8072193 | 0.95 | GAA (0.38) | GAAHSD17B10AMY1AMPLALDH1A1 | |
| SCHEMBL8084876 | 0.95 | GAA (0.38) | GAAHSD17B10AMY1AMPLALDH1A1 | |
| SCHEMBL8084853 | 0.95 | GAA (0.38) | GAAHSD17B10AMY1AMPLALDH1A1 | |
| SCHEMBL8084715 | 0.95 | GAA (0.38) | GAAHSD17B10AMY1AMPLALDH1A1 | |
| SCHEMBL5718608 | 0.95 | GAA (0.38) | GAAHSD17B10AMY1AMPLALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2579377-B1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME | UBE INDUSTRIES (JP) | 2014-09-03 | — | — | EP | claimed |
| CN-111491891-B | EMM-31 material, method and use thereof | 埃克森美孚科技工程公司 | 2023-07-04 | — | — | CN | disclosed |
| US-11041027-B2 | Polymerization process for producing ethylene based polymers | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-06-22 | — | — | US | disclosed |
| US-20210111346-A1 | CONJUGATED POLYMERS WITH MULTISTAGE SIDE-CHAIN CLEAVAGE | NAVY, SECRETARY OF THE UNITED STATES OF AMERICA | 2021-04-15 | — | — | US | disclosed |
| CN-112261970-A | 3- (5-hydroxy-1-oxoisoindolin-2-yl) piperidine-2, 6-dione derivatives and their use in the treatment of IKAROS family Zinc finger 2(IKZF2) dependent diseases | 诺华股份有限公司 | 2021-01-22 | — | — | CN | disclosed |
| EP-3736299-A1 | A POLYMERIZATION PROCESS FOR PRODUCING ETHYLENE BASED POLYMERS | Dow Global Technologies Llc (US) | 2020-11-11 | — | — | EP | disclosed |
| EP-3317312-B1 | A POLYMERIZATION PROCESS FOR PRODUCING ETHYLENE BASED POLYMERS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-06-10 | — | — | EP | disclosed |
| US-10597473-B2 | Polymerization process for producing ethylene based polymers | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-03-24 | — | — | US | disclosed |
| EP-3317313-B1 | A POLYMERIZATION PROCESS FOR PRODUCING ETHYLENE BASED POLYMERS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-02-19 | — | — | EP | disclosed |
| WO-2019005247-A9 | CONJUGATED POLYMERS WITH MULTISTAGE SIDE-CHAIN CLEAVAGE | GEORGIA TECH RESEARCH CORPORATION (US) | 2019-03-07 | — | — | WO | disclosed |
| EP-2491062-A1 | PROCESS FOR SELECTIVELY POLYMERIZING ETHYLENE AND CATALYST THEREFOR | Dow Global Technologies LLC (US) | 2012-08-29 | — | — | EP | disclosed |
| WO-2011146291-A1 | PROCESS FOR SELECTIVELY POLYMERIZING ETHYLENE AND CATALYST THEREFOR | DOW GLOBAL TECHNOLOGIES LLC (US) | 2011-11-24 | — | — | WO | disclosed |
| US-20110282018-A1 | PROCESS FOR SELECTIVELY POLYMERIZING ETHYLENE AND CATALYST THEREFOR | DOW GLOBAL TECHNOLOGIES LLC | 2011-11-17 | — | — | US | disclosed |
| US-20100239496-A1 | Imaging agents for detecting neurological disorders | SIEMENS MEDICAL SOLUTIONS USA, INC. (US) | 2010-09-23 | — | — | US | disclosed |
| EP-0758013-B1 | Liquid crystalline optical film, compensating film for liquid crystal display and liquid crystal display | NIPPON OIL CO LTD (JP) | 2000-10-11 | — | — | EP | disclosed |
| US-5855971-A | Liquid crystalline optical film, compensating film for liquid crystal display comprising the liquid crystalline optical film, and liquid crystal display having the compensating film | NIPPON OIL COMPANY, LIMITED (JP) | 1999-01-05 | — | — | US | disclosed |
| EP-0758013-A1 | Liquid crystalline optical film, compensating film for liquid crystal display and liquid crystal display | NIPPON OIL COMPANY, LIMITED (JP) | 1997-02-12 | — | — | EP | disclosed |
| EP-0121326-B1 | ALKANEDIYL BRIDGED BENZIMIDAZOLO MONOMETHINE CYANINE DYES, PROCESSES FOR THEIR PREPARATION, AND PHOTOGRAPHIC EMULSIONS AND ELEMENTS CONTAINING SUCH DYES | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1989-05-17 | — | — | EP | disclosed |
| US-4490463-A | SENSITIZERS | EASTMAN KODAK COMPANY (US) | 1984-12-25 | — | — | US | disclosed |
| EP-0121326-A2 | Alkanediyl bridged benzimidazolo monomethine cyanine dyes, processes for their preparation, and photographic emulsions and elements containing such dyes | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1984-10-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110282018-A1 | PROCESS FOR SELECTIVELY POLYMERIZING ETHYLENE AND CATALYST THEREFOR | WEE2, NOTUM, WEE1 | GAA 3119/4885HSD17B10 2242/4885AMY1A 1413/4885 |
| US-20100239496-A1 | Imaging agents for detecting neurological disorders | MAPT, APP, PSEN1 | GAA 219/4885HSD17B10 3820/4885AMY1A 205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.